Our Culture
What you believe and what you value as an organization matters. Discover the DNA of our firm.
Director of Technical Research
2022
Farcast Biosciences (2017-2020)
Bangalore, India | Director R&D, Intellectual Property
General Electric (2010 - 2017)
Bangalore, India | Lead Intellectual Property Professional
Brigham & Women’s Hospital, Harvard-MIT Division of Health Science and Technology (2007 - 2010)
Cambridge, MA | Post-doctoral fellow
Indian Institute of Science (2002-2007)
PhD | Organic Chemistry
Indian Institute of Science (1999 - 2002)
Master of Science | Chemical Sciences
Padmaparna joined Sands Capital in 2022 as the Director of Technical Research, reporting to Parker Cassidy. Prior to that, Padmaparna spent 12 years in large multi-national and startup companies, working across different life sciences tools and diagnostic programs. In those roles, she has led the creation of patent portfolios and performed technology and intellectual property analysis to identify R&D and inorganic growth opportunities. The work contributed to initiation and shaping of various internal research programs, and led to some key collaborations/acquisitions. Padmaparna did her PhD from Indian Institute of Science (India) in Bioorganic Chemistry and her post-doctoral research in Harvard Medical School/Brigham & Women’s Hospital in the area of targeted drug delivery in cancer.
An independent, staff-owned firm founded in 1992 and headquartered in the Washington, D.C. area with offices in London and Singapore, Sands Capital managed more than $46 billion in client assets as of September 30, 2023.
For institutional and professional investors only. Investment advisory fees are described in Part II of the adviser’s Form ADV.
